Cargando…

The Acute Effects of Amyloid-Beta(1–42) on Glutamatergic Receptor and Transporter Expression in the Mouse Hippocampus

Alzheimer’s disease (AD) is the leading type of dementia worldwide. Despite an increasing burden of disease due to a rapidly aging population, there is still a lack of complete understanding of the precise pathological mechanisms which drive its progression. Glutamate is the main excitatory neurotra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeung, Jason H. Y., Palpagama, Thulani H., Tate, Warren P., Peppercorn, Katie, Waldvogel, Henry J., Faull, Richard L. M., Kwakowsky, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978747/ https://www.ncbi.nlm.nih.gov/pubmed/32009891 http://dx.doi.org/10.3389/fnins.2019.01427

Ejemplares similares

Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex
por: Yeung, Jason H. Y., et al.
Publicado: (2021)

Beta-Amyloid (Aβ(1-42)) Increases the Expression of NKCC1 in the Mouse Hippocampus
por: Lam, Patricia, et al.
Publicado: (2022)

The Interplay Between Beta-Amyloid 1–42 (Aβ(1–42))-Induced Hippocampal Inflammatory Response, p-tau, Vascular Pathology, and Their Synergistic Contributions to Neuronal Death and Behavioral Deficits
por: Calvo-Flores Guzmán, Beatriz, et al.
Publicado: (2020)

The effects of amyloid-beta on hippocampal glutamatergic receptor and transporter expression
por: Kwakowsky, Andrea, et al.
Publicado: (2020)

Amyloid-Beta(1-42) -Induced Increase in GABAergic Tonic Conductance in Mouse Hippocampal CA1 Pyramidal Cells
por: Calvo-Flores Guzmán, Beatriz, et al.
Publicado: (2020)

GABA(A) Receptors Are Well Preserved in the Hippocampus of Aged Mice
por: Palpagama, Thulani H., et al.
Publicado: (2019)

EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer’s Disease
por: Yeung, Jason H. Y., et al.
Publicado: (2021)

The Role of Microglia and Astrocytes in Huntington’s Disease
por: Palpagama, Thulani H., et al.
Publicado: (2019)

An α5 GABAA Receptor Inverse Agonist, α5IA, Attenuates Amyloid Beta-Induced Neuronal Death in Mouse Hippocampal Cultures
por: Vinnakota, Chitra, et al.
Publicado: (2020)

The effect of age and sex on the expression of GABA signaling components in the human hippocampus and entorhinal cortex
por: Ethiraj, Jayarjun, et al.
Publicado: (2021)

Treatment of beta amyloid 1–42 (Aβ(1–42))-induced basal forebrain cholinergic damage by a non-classical estrogen signaling activator in vivo
por: Kwakowsky, Andrea, et al.
Publicado: (2016)

Sex- and age-related changes in GABA signaling components in the human cortex
por: Pandya, Madhavi, et al.
Publicado: (2019)

mGluR1α expression in the hippocampus, subiculum, entorhinal cortex and superior temporal gyrus in Alzheimer’s disease
por: Yeung, J.H.Y., et al.
Publicado: (2022)

Current and Possible Future Therapeutic Options for Huntington’s Disease
por: Ferguson, Mackenzie W., et al.
Publicado: (2022)

iGluR expression in the hippocampal formation, entorhinal cortex, and superior temporal gyrus in Alzheimer’s disease
por: Yeung, Jason HY, et al.
Publicado: (2022)

Secreted Amyloid Precursor Protein Alpha, a Neuroprotective Protein in the Brain Has Widespread Effects on the Transcriptome and Proteome of Human Inducible Pluripotent Stem Cell-Derived Glutamatergic Neurons Related to Memory Mechanisms
por: Peppercorn, Katie, et al.
Publicado: (2022)

Therapeutic potential of alpha 5 subunit containing GABA(A) receptors in Alzheimer’s disease
por: Kwakowsky, Andrea, et al.
Publicado: (2021)

Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer’s Disease
por: Kwakowsky, Andrea, et al.
Publicado: (2016)

Secreted Amyloid Precursor Protein Alpha (sAPPα Regulates the Cellular Proteome and Secretome of Mouse Primary Astrocytes
por: Peppercorn, Katie, et al.
Publicado: (2023)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

Impaired Expression of GABA Signaling Components in the Alzheimer’s Disease Middle Temporal Gyrus
por: Govindpani, Karan, et al.
Publicado: (2020)

Neuroprotective Effect of Caffeine in Alzheimer’s Disease
por: M Yelanchezian, Y Mukish, et al.
Publicado: (2022)

Gamma-aminobutyric acid A receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway
por: Kwakowsky, Andrea, et al.
Publicado: (2018)

Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease
por: Govindpani, Karan, et al.
Publicado: (2017)

Tyramine and Amyloid Beta 42: A Toxic Synergy
por: Dhakal, Sudip, et al.
Publicado: (2020)

AFM Probing of Amyloid-Beta 42 Dimers and Trimers
por: Maity, Sibaprasad, et al.
Publicado: (2020)

Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy
por: de Kort, Anna M., et al.
Publicado: (2023)

Amyloid-beta 42 adsorption following serial tube transfer
por: Toombs, Jamie, et al.
Publicado: (2014)

EAAT2 as a therapeutic research target in Alzheimer's disease: A systematic review
por: Wood, Oliver W. G., et al.
Publicado: (2022)

ATM rules neurodevelopment and glutamatergic transmission in the hippocampus but not in the cortex
por: Focchi, Elisa, et al.
Publicado: (2022)

Microglia control glutamatergic synapses in the adult mouse hippocampus
por: Basilico, Bernadette, et al.
Publicado: (2021)

Glycosyl chains and 25‐hydroxycholesterol contribute to the intracellular transport of amyloid beta (Aβ‐42) in Jurkat T cells
por: Sharma, Neha, et al.
Publicado: (2017)

Time-dependent changes in gene expression induced by secreted amyloid precursor protein-alpha in the rat hippocampus
por: Ryan, Margaret M, et al.
Publicado: (2013)

Interaction of the Molecular Chaperone DNAJB6 with Growing Amyloid-beta 42 (Aβ42) Aggregates Leads to Sub-stoichiometric Inhibition of Amyloid Formation
por: Månsson, Cecilia, et al.
Publicado: (2014)

Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?
por: Govindpani, Karan, et al.
Publicado: (2019)

Mitochondrial Disruption by Amyloid Beta 42 Identified by Proteomics and Pathway Mapping
por: Sinclair, Patricia, et al.
Publicado: (2021)

The role of glutamatergic pathway between septum and hippocampus in the memory formation
por: Khakpai, Fatemeh, et al.
Publicado: (2013)

Secreted Amyloid Precursor Protein-Alpha Promotes Arc Protein Synthesis in Hippocampal Neurons
por: Livingstone, Rhys W., et al.
Publicado: (2019)

Amyloid-Beta 1-42 Cross-Reactive Antibody Prevalent in Human Sera May Contribute to Intraneuronal Deposition of A-Beta-P-42
por: Vojdani, Aristo, et al.
Publicado: (2018)

Nasal mucosal inhalation of amyloid-beta peptide 3–10 defective adenovirus attenuates cytotoxicity induced by beta-amyloid (1–42)
por: Jiang, Tongzi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u2c5qhui4c20r1265r27182s9b